These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4009338)

  • 1. Management of hydrocephalus in infancy: use of acetazolamide and furosemide to avoid cerebrospinal fluid shunts.
    Shinnar S; Gammon K; Bergman EW; Epstein M; Freeman JM
    J Pediatr; 1985 Jul; 107(1):31-7. PubMed ID: 4009338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, controlled trial of acetazolamide and furosemide in posthemorrhagic ventricular dilation in infancy: follow-up at 1 year.
    Kennedy CR; Ayers S; Campbell MJ; Elbourne D; Hope P; Johnson A
    Pediatrics; 2001 Sep; 108(3):597-607. PubMed ID: 11533324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International randomised controlled trial of acetazolamide and furosemide in posthaemorrhagic ventricular dilatation in infancy. International PHVD Drug Trial Group.
    Lancet; 1998 Aug; 352(9126):433-40. PubMed ID: 9708751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetazolamide without frusemide in the treatment of post-haemorrhagic hydrocephalus.
    Mercuri E; Faundez JC; Cowan F; Dubowitz L
    Acta Paediatr; 1994 Dec; 83(12):1319-21. PubMed ID: 7734881
    [No Abstract]   [Full Text] [Related]  

  • 5. Acetazolamide in posthaemorrhagic ventricular dilatation.
    Raupp P
    Lancet; 1998 Nov; 352(9139):1548-9. PubMed ID: 9820321
    [No Abstract]   [Full Text] [Related]  

  • 6. Short-term medical management of hydrocephalus.
    Poca MA; Sahuquillo J
    Expert Opin Pharmacother; 2005 Aug; 6(9):1525-38. PubMed ID: 16086640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetazolamide and furosemide for posthemorrhagic hydrocephalus of the newborn.
    Libenson MH; Kaye EM; Rosman NP; Gilmore HE
    Pediatr Neurol; 1999 Mar; 20(3):185-91. PubMed ID: 10207925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Conservative treatment of non-resorptive hydrocephalus in premature infants].
    Stephani U; Harms K; Herting E; Speer CP
    Monatsschr Kinderheilkd; 1989 Apr; 137(4):218-24. PubMed ID: 2733700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberculous hydrocephalus: comparison of different treatments with regard to ICP, ventricular size and clinical outcome.
    Schoeman J; Donald P; van Zyl L; Keet M; Wait J
    Dev Med Child Neurol; 1991 May; 33(5):396-405. PubMed ID: 2065826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetazolamide plus furosemide for periventricular dilatation: lessons for drug therapy in children.
    Hack M; Cohen AR
    Lancet; 1998 Aug; 352(9126):418-9. PubMed ID: 9708745
    [No Abstract]   [Full Text] [Related]  

  • 11. Nephrocalcinosis complicating medical treatment of posthemorrhagic hydrocephalus.
    Stafstrom CE; Gilmore HE; Kurtin PS
    Pediatr Neurol; 1992; 8(3):179-82. PubMed ID: 1622512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diuretic therapy for newborn infants with posthemorrhagic ventricular dilatation.
    Whitelaw A; Kennedy CR; Brion LP
    Cochrane Database Syst Rev; 2001; 2001(2):CD002270. PubMed ID: 11406041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posthemorrhagic hydrocephalus in preterm infants: long-term follow-up and shunt-related complications.
    Reinprecht A; Dietrich W; Berger A; Bavinzski G; Weninger M; Czech T
    Childs Nerv Syst; 2001 Nov; 17(11):663-9. PubMed ID: 11734984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of acetazolamide to decrease cerebrospinal fluid production in chronically ventilated patients with ventriculopleural shunts.
    Carrion E; Hertzog JH; Medlock MD; Hauser GJ; Dalton HJ
    Arch Dis Child; 2001 Jan; 84(1):68-71. PubMed ID: 11124792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posthemorrhagic hydrocephalus in the preterm infant.
    Chaplin ER; Goldstein GW; Myerberg DZ; Hunt JV; Tooley WH
    Pediatrics; 1980 May; 65(5):901-9. PubMed ID: 7367137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ventriculosubgaleal shunts for posthemorrhagic hydrocephalus in premature infants.
    Willis BK; Kumar CR; Wylen EL; Nanda A
    Pediatr Neurosurg; 2005; 41(4):178-85. PubMed ID: 16088252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isosorbide in the management of infantile hydrocephalus.
    Lorber J; Salfield S; Lonton T
    Dev Med Child Neurol; 1983 Aug; 25(4):502-11. PubMed ID: 6618028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shunting outcomes in posthemorrhagic hydrocephalus: results of a Hydrocephalus Clinical Research Network prospective cohort study.
    Wellons JC; Shannon CN; Holubkov R; Riva-Cambrin J; Kulkarni AV; Limbrick DD; Whitehead W; Browd S; Rozzelle C; Simon TD; Tamber MS; Oakes WJ; Drake J; Luerssen TG; Kestle J;
    J Neurosurg Pediatr; 2017 Jul; 20(1):19-29. PubMed ID: 28452657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric hydrocephalus: systematic literature review and evidence-based guidelines. Part 2: Management of posthemorrhagic hydrocephalus in premature infants.
    Mazzola CA; Choudhri AF; Auguste KI; Limbrick DD; Rogido M; Mitchell L; Flannery AM;
    J Neurosurg Pediatr; 2014 Nov; 14 Suppl 1():8-23. PubMed ID: 25988778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrocephalus shunt infections.
    Bayston R
    J Antimicrob Chemother; 1994 Aug; 34 Suppl A():75-84. PubMed ID: 7844076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.